ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
83,255
0,16%
Bitcoin
64 269,98
0,42%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Organon and Co (OGN)

  7. Organon and Co (OGN) Actualités

OGN Organon and Co

19,61
0,11 (0,56%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Organon and Co OGN NYSE Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,11 0,56% 19,61 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
20,00 19,41 20,30 19,61 19,50
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/5/202413:30BWOrganon Reports Results for the First Quarter Ended March..
09/4/202414:13BWProlia ® とXgeva ®..
08/4/202420:31BWL'essai clinique comparatif de phase 3 du candidat..
08/4/202412:15BWOrganon To Report First Quarter 2024 Results and Host..
08/4/202412:00BWPhase 3 Comparative Clinical Study of Prolia® and Xgeva®..
08/3/202415:01PRNCAOn International Women's Day, Organon Canada is encouraging..
01/3/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202414:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
23/2/202417:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202414:00BWOrganon Announces HADLIMA™ (adalimumab-bwwd) Has Been..
15/2/202413:48EDGAR2Form 8-K - Current report
15/2/202413:30BWOrganon Reports Results for the Fourth Quarter and Full Year..
13/2/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202413:30BWOrganon To Report Fourth Quarter and Full Year Results and..
10/1/202413:33BWOrganon’s XACIATO™ (clindamycin phosphate) Vaginal Gel 2%..
08/1/202413:30BWOrganon affirms 2023 revenue and Adjusted EBITDA guidance..
21/12/202313:30BWOrganon To Present at the 42nd Annual J.P. Morgan Healthcare..
19/12/202314:30BWOrganon et Lilly concluent un accord de commercialisation en..
19/12/202310:11BWOrganon と Lilly、ヨーロッパで 2 種類の片頭痛薬商業化契約を締結
19/12/202303:26BWOrganon und Lilly schließen Vermarktungsvereinbarung für..
18/12/202313:30BWOrganon & Lilly Enter Commercialization Agreement in Europe..
05/12/202322:31EDGAR2Form 8-K - Current report
21/11/202313:30BWOrganon To Present at the Piper Sandler 35th Annual..
07/11/202322:15GLOBESamsung Bioepis & Organon Announce FDA Acceptance of..
03/11/202312:52EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202312:38EDGAR2Form 8-K - Current report
02/11/202312:30BWOrganon Reports Results for the Third Quarter Ended..
01/11/202312:30BWOrganon and Sempre Health Announce Collaboration on New..
26/10/202313:00PRNCAOrganon Canada annonce la disponibilité d'une préparation..
19/10/202313:30BWOrganon To Report Third Quarter Results and Host Conference..
14/10/202300:02PRNUSLululemon Athletica & Hubbell Set to Join S&P 500; Others to..
27/9/202321:13BWOrganon figure sur la liste « Change the World » de Fortune..
27/9/202319:43BWオルガノン、フォーチュン誌の2023年チェンジ・ザ・ワールドリストで避妊の選択肢へのアクセスを拡大するリーダーシップで表彰される
27/9/202319:33BWOrganon auf der Fortune „Change the World“-Liste 2023 für..
27/9/202313:30BWOrganon Recognized on Fortune’s 2023 Change the World List..
26/9/202313:01PRNCAOn World Contraception Day, Organon Canada Declares Support..
14/9/202323:12BWFirst Real-World Observational Study of the JADA® System, a..
06/9/202301:38BWオルガノン、2人のリーダー任命で研究開発の専門知識を強化
05/9/202322:27BWOrganon renforce ses capacités de recherche et de..
05/9/202319:52BWOrganon stärkt Forschungs- und Entwicklungskompetenz mit..
05/9/202316:00BWOrganon Bolsters Research & Development Expertise with Two..
09/8/202314:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202313:58EDGAR2Form 8-K - Current report
08/8/202313:30BWOrganon Reports Results for the Second Quarter Ended June..
01/8/202313:00GLOBESamsung Bioepis & Organon Announce Topline Results from..
17/7/202313:30BWOrganon To Report Second Quarter Results and Host Conference..
07/7/202322:05EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NYSE
OGN
Organon
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés